Latest News and Press Releases

NeOnc (NASDAQ:NTHI) is developing therapies and delivery technologies targeting aggressive brain cancers and CNS-related conditions, and could be part of t

Keeps TRT legitimate? Compounded, $49 start, lab required, enclomiphene off-label, FDA 2025 blood pressure warning, DEA 2026 rules.

Tevogen advances strategic acquisition initiatives that, if consummated, could support financial self-sufficiency and ~$100M in annual revenue.

OAKBROOK TERRACE, Illinois, May 28, 2026 (GLOBE NEWSWIRE) -- As healthcare delivery grows more complex, addressing persistent risks requires a focused, industrywide effort. Through Joint...

Teladoc Health has joined Walmart's Better Care Services, expanding access to the largest nationwide network of virtual care providers.

May 28, 2026For the first time, Disney stories and characters will be integrated into Philips Ambient Experience for MRI at medical facilities around the world to help create calmer, more comfortable...

Ultimo expands its Intelligent Asset Management platform with three purpose-built digital workers for planning, maintenance, and safety - with early custom

WESEL, Germany, May 28, 2026 (GLOBE NEWSWIRE) -- Ultimo, ein führender Anbieter von KI-augmentiertem Enterprise Asset Management (EAM), hat drei neue Digital Workers für industrielle...

Thousands of people march to protest Ford’s hospital privatization, Demand he return that funding to our public hospitals

BOSTON, May 28, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana”), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3...